Other languages Cyclopharm Limited

Equities

CYC

AU000000CYC5

Delayed Australian S.E. Other stock markets 10:55:23 2024-04-29 pm EDT			5-day change	1st Jan Change
1.775 ^AUD	+0.85%		+1.43%	-7.79%

Mar. 19	Cyclopharm's Technegas Device Carries Out Imaging of First US Patients	MT
Mar. 18	Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cyclopharm's Technegas Device Carries Out Imaging of First US Patients	Mar. 19
Cyclopharm Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27
Cyclopharm Limited Appoints John Wigglesworth to its Board as Non- Executive Director	Feb. 18
Cyclopharm Appoints CFO; Shares Rise 3%	Feb. 12
Cyclopharm Signs First US Deal for Inhalable Imaging Product	Dec. 05
Argenica Therapeutics Appoints Nonexecutive Chair	Nov. 29
Cyclopharm Advances Rollout of Imaging Drug in the US	Nov. 15
Cyclopharm Says U.S. SNMMI Confirms FDA Nod for Technegas	23-10-04
Cyclopharm Secures US FDA Clearance for Inhalable Imaging Product; Shares Rise 5%	23-10-02
Cyclopharm Limited Declares Unfranked Interim Dividend for the Six Months Ended June 30, 2023, Payable on 11 September 2023	23-08-21
Cyclopharm Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-21
US FDA Completes Site Inspection for Cyclopharm’s Technegas Facility	23-08-08
Australian Shares Retreat Ahead of Federal Budget	23-05-09
Cyclopharm Secures US FDA Inspection Date for Imaging Drug Production Facility; Shares Rise 4%	23-05-09
US FDA Confirms Receipt of Cyclopharm's Response Submission for Inhalable Imaging Agent	23-04-24
Cyclopharm Takes Over Denmark-based DuPharma ApS	23-04-19
Cyclopharm Limited acquired Dupharma Aps.	23-04-19
Cyclopharm Files Formal Reply to US FDA for Inhalable Imaging Agent	23-03-30
Cyclopharm Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-19
Cyclopharm Limited Announces Dividend for A Period of Six Months Ended December 31, 2022, Payable on April 4 2023	23-02-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cyclopharm Limited

Equities

CYC

AU000000CYC5

Other languages

Filters